Clinical Trial Update: Efficacy Regarding Renal Function of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy of everolimus with a standard immunosuppressive regimen in lung transplant recipients, focusing on renal function o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplantation

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Lung Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2019-03-14